Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study

NCT: NCT07655674 · NOT_YET_RECRUITING

NCT IDNCT07655674
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2028-06-30
SponsorThe First Affiliated Hospital of Soochow University (OTHER)
First posted
Last updated

Brief Summary

In endoscopic treatment for gastric submucosal tumors arising from the muscularis propria, does robot-assisted surgery yield a higher serosa preservation rate, shorter operative time and lower complication rates than conventional endoscopic procedures?

Frequently Asked Questions

What is Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study?

Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study is a clinical trial registered under NCT07655674. Current status: NOT_YET_RECRUITING.

What is the status of NCT07655674?

The current status of NCT07655674 (Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study) is: NOT_YET_RECRUITING.

When did Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study start?

Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑